JPRN-UMIN000042622已完成未知
Tumor differentiation as a risk factor in T1 colorectal cancer - Tumor differentiation as a risk factor in T1 colorectal cancer
Showa University Northern Yokohama Hospital0 个研究点目标入组 971 人开始时间: 2020年12月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 971
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 130years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with preoperative chemotherapy or radiotherapy
研究者
相似试验
Unknown
不适用
Comparing tumour heterogeneity in primary tumour, circulating tumour cells and metastasesSCLC niet kleincellig longcarcinoom, longkankerlungcancer, tumour heterogeneity, tumor heterogeniteit, CTC, circulating tumour cell, circulerende tumor celNL-OMON29203niversity Medical Centre Groningen30
尚未招募
不适用
Comparing tumour heterogeneity in primary tumour, circulating tumour cells and its metastaseslungcancer1002765510029107NL-OMON45251niversitair Medisch Centrum Groningen50
尚未招募
不适用
Analysis of the risk profile of tumor patientsDRKS00033880niversitätsklinikum Augsburg, Medizinische Fakultät, Universität Augsburg2,000
招募中
不适用
Characterisation of tumour heterogeneity and identification of adaptive resistance mechanisms of metastatic castration-resistant prostate carcinomaC61Malignant neoplasm of prostateDRKS00028021Klinik für Nuklearmedizin am Universitätsklinikum Augsburg45
尚未招募
不适用
ational Cancer Institute Cancer Awareness Risk assessment and Early detection of Prostate Oral Head Neck CancersCTRI/2022/11/047056Bayer Pharmaceuticals Pvt Ltd